News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
465,088 Results
Type
Article (25223)
Company Profile (169)
Press Release (439696)
Section
Business (130698)
Career Advice (552)
Deals (22178)
Drug Delivery (37)
Drug Development (79601)
Employer Resources (54)
FDA (13139)
Job Trends (9946)
News (244075)
Policy (20517)
Tag
Academia (1825)
Alliances (35029)
Alzheimer's disease (1176)
Approvals (13045)
Artificial intelligence (102)
Bankruptcy (182)
Best Places to Work (8613)
Biotechnology (130)
Breast cancer (91)
Cancer (801)
Career advice (479)
CAR-T (58)
Cell therapy (182)
Clinical research (63991)
Collaboration (260)
Compensation (113)
COVID-19 (2057)
Cystic fibrosis (69)
Data (705)
Diabetes (102)
Diagnostics (5114)
Earnings (48382)
Events (73345)
Executive appointments (198)
FDA (13488)
Funding (231)
Gene therapy (115)
GLP-1 (431)
Government (2546)
Healthcare (14953)
Infectious disease (2109)
Inflammatory bowel disease (102)
Interviews (79)
IPO (11509)
Job creations (1566)
Job search strategy (430)
Layoffs (257)
Legal (3063)
Lung cancer (143)
Manufacturing (94)
Medical device (10007)
Medtech (10007)
Mergers & acquisitions (10741)
Metabolic disorders (265)
Neuroscience (1397)
NextGen Class of 2024 (4322)
Non-profit (2763)
Northern California (997)
Obesity (142)
Opinion (126)
Parkinson's disease (66)
Patents (62)
People (38414)
Phase I (20437)
Phase II (28461)
Phase III (20771)
Pipeline (177)
Postmarket research (2120)
Preclinical (7359)
Radiopharmaceuticals (235)
Rare diseases (157)
Real estate (3034)
Regulatory (15874)
Research institute (1907)
Resumes & cover letters (77)
Southern California (901)
Startups (2466)
United States (8964)
Vaccines (375)
Weight loss (91)
Date
Today (131)
Last 7 days (510)
Last 30 days (2331)
Last 365 days (31376)
2024 (25307)
2023 (34712)
2022 (42865)
2021 (45045)
2020 (41876)
2019 (33352)
2018 (24996)
2017 (24904)
2016 (22836)
2015 (26651)
2014 (19306)
2013 (14611)
2012 (15212)
2011 (15637)
2010 (14761)
Location
Africa (388)
Arizona (82)
Asia (27735)
Australia (5396)
California (2190)
Canada (906)
China (166)
Colorado (95)
Connecticut (89)
Europe (63736)
Florida (296)
Georgia (75)
Illinois (186)
Indiana (130)
Kansas (81)
Maryland (349)
Massachusetts (1717)
Michigan (87)
Minnesota (166)
New Jersey (609)
New York (639)
North Carolina (579)
Northern California (997)
Ohio (96)
Pennsylvania (621)
South America (512)
Southern California (901)
Texas (316)
Utah (58)
Washington State (260)
465,088 Results for "aperio clinical outcomes".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration.
April 29, 2024
·
2 min read
Business
Aperio Continues Growth with Appointment of Eric Ross as Chief Commercial Officer
Aperio Clinical Outcomes, a prominent data focused clinical research organization, appoints Eric Ross as Chief Commercial Officer, as the company adds additional infrastructure to support continued growth.
October 3, 2023
·
2 min read
Press Releases
Madrigal Pharmaceuticals Completes Enrollment of Clinical Outcomes Study of Resmetirom in Patients with Compensated NASH/MASH Cirrhosis
October 22, 2024
·
9 min read
Genetown
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA.
March 11, 2024
·
12 min read
Lone Star Bio
TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities
TFF Pharmaceuticals, Inc. today announced that the Company has engaged Outcome Capital as a strategic advisor for the purpose of evaluating potential corporate partnerships and licensing opportunities.
June 26, 2024
·
5 min read
Press Releases
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
October 10, 2024
·
6 min read
Drug Development
Results of Woolsey Pharmaceuticals’ Phase 2a Study of BRAVYL in ALS Patients Shows Statistically Significant Reduction in Neurofilament Light and Directionally Improved Clinical Outcomes
Woolsey Pharmaceuticals, a clinical-stage drug development company, announced that its investigational drug, CIRARA, was well tolerated and exhibited statistically significant reductions in a key biomarker, Neurofilament Light (NfL), in the REAL Amyotrophic Lateral Sclerosis (ALS) study.
June 19, 2024
·
4 min read
Business
Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and Palantir Technologies Inc.
April 25, 2024
·
6 min read
Drug Development
Kinaset Therapeutics Debuts Positive Outcomes Data from Phase 1b Study of KN-002 at the 2024 American Thoracic Society (ATS) International Conference
Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced positive outcomes from Part 2 of a multi-part Phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of its orally inhaled pan-JAK inhibitor KN-002.
May 21, 2024
·
5 min read
Drug Development
Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced plans to advance investigational plozasiran into a Phase 3 cardiovascular outcomes trial called CAPITAN.
June 25, 2024
·
12 min read
1 of 46,509
Next